sigma aldrich igf-1 lr3 Igf 1 1mg IGF-1 LR3 | 99%+ Purity,
Description
M., Pareti F
PDI was found to be consistently modified by 4-HNE, specifically at the cysteine residue in its active site
Cell Host Microbe 12 , 717729 (2012)
Upcoming studies may reveal additional therapeutic potential for edaravone, including its synergistic interactions with other compounds or its utility in addressing a wider spectrum of neurological diseases
